Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 100.84B | 100.84B | 88.65B | 87.46B | 57.02B | 51.59B |
Gross Profit | 48.42B | 48.42B | 37.45B | 40.97B | 26.69B | 22.94B |
EBITDA | 33.12B | 33.59B | 27.50B | 30.41B | 18.71B | 16.64B |
Net Income | 23.62B | 23.62B | 18.80B | 20.90B | 12.82B | 11.07B |
Balance Sheet | ||||||
Total Assets | 190.98B | 190.98B | 162.74B | 150.51B | 126.88B | 105.48B |
Cash, Cash Equivalents and Short-Term Investments | 82.57B | 82.57B | 79.09B | 67.01B | 60.30B | 43.09B |
Total Debt | 106.00M | 106.00M | 112.00M | 82.00M | 598.00M | 92.00M |
Total Liabilities | 37.78B | 37.78B | 31.02B | 36.05B | 30.84B | 20.36B |
Stockholders Equity | 153.20B | 153.20B | 131.71B | 114.50B | 96.04B | 85.12B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 26.46B | 15.66B | 14.34B | 14.55B | 7.71B |
Operating Cash Flow | 0.00 | 27.16B | 16.28B | 15.26B | 15.07B | 8.05B |
Investing Cash Flow | 0.00 | -5.54B | -4.54B | -2.95B | -15.39B | 298.00M |
Financing Cash Flow | 0.00 | -6.44B | -6.41B | -4.54B | -2.47B | -2.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥286.97B | 24.93 | 1.32% | 34.01% | 34.65% | ||
69 Neutral | ¥30.11B | 34.59 | 1.02% | 23.28% | -57.08% | ||
69 Neutral | ¥373.88B | 20.84 | 0.51% | 5.14% | 12.51% | ||
60 Neutral | $46.60B | 4.15 | -11.40% | 4.15% | 1.85% | -42.71% | |
60 Neutral | ¥618.34B | 25.71 | 1.05% | 5.92% | 12.22% | ||
― | $10.43B | 41.49 | 8.33% | 1.58% | ― | ― | |
46 Neutral | ¥170.57B | 183.27 | 0.24% | 5.41% | -28.32% |